Casdin Capital, LLC Pliant Therapeutics, Inc. Transaction History

Casdin Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $8.16 Million - $11.3 Million	-577,108 Reduced 36.59%	1,000,000 $14.9 Million
Q3 2023 Nov 14, 2023	SELL	$14.58 - $20.15 $1.79 Million - $2.48 Million	-122,892 Reduced 7.23%	1,577,108 $27.3 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $453,000 - $764,000	25,000 Added 1.49%	1,700,000 $30.8 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $15.7 Million - $23.5 Million	925,000 Added 123.33%	1,675,000 $32.4 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $5.75 Million - $18.2 Million	750,000 New	750,000 $15.7 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.